# Electra Therapeutics, Inc. (ETRA)

> Source: Nexqual · https://nexqual.com/ETRA · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Electra Therapeutics, Inc. (ETRA), nexqual.com/ETRA" · informational, not investment advice.

**Price:** USD 8.75 (-2.13% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 8.94 · day 8.58–8.99 · 52w 8.5–15.5 · market cap $549M · NMS

## Key facts
- Analysts: Buy (mean 2.00 on a 1–5 scale) (4 analysts), mean target USD 33.33 (range 32–36).
- Total return with dividends: 1Y -34.0% vs S&P 500 +18.1%; 5Y -34.0% vs S&P 500 +85.1%.

## Analysts
Consensus Buy (mean 2.00 on a 1–5 scale), 4 analysts; mean target USD 33.33 (low 32, high 36).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-13 | Jefferies | Initiated | Buy | $32 |
| 2026-10-13 | Evercore ISI Group | Initiated | Outperform | $36 |
| 2026-10-13 | TD Cowen | Initiated | Buy |  |
| 2026-10-13 | Cantor Fitzgerald | Initiated | Overweight |  |

## Total return (dividends reinvested)
|  | 1Y (from 2026-09-18) | 5Y (from 2026-09-14) |
|---|---|---|
| Total return | -34.0% | -34.0% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | — | — |
| Volatility (annualized) | 61.0% | 45.5% |
| Max drawdown | -38.1% (Sep 2026→Oct 2026) | -34.0% (Sep 2026→Oct 2026) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/ETRA · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt